Headlines

Boston Scientific (BSX) says that the cybersecurity incident is likely to materially affect Q3 and FY26 results; says it is unlikely to meet prior net sales growth and Adj. EPS guidance

Newsquawk Staff ·

Boston Scientific (BSX) says that the cybersecurity incident is likely to materially affect Q3 and FY26 results; says it is unlikely to meet prior net sales growth and Adj. EPS guidance.

Related headlines